Clinical Trial Update: Serological Response to Retreatment of Serofast Early Syphilis Cases With Benzathine Penicillin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating serological response to retreatment with benzathine penicillin in serofast early syphilis cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syphilis

Drugs mentioned

• benzathine penicillin (benzathine penicillin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Syphilis | Phase 4 | Status: UNKNOWN